Dentzer James E has filed 18 insider transactions across 2 companies since January 2023.
Most recent transaction: a transaction of 100 shares of CURIS INC ($CRIS) on March 20, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 20, 2026 | CURIS INC | $CRIS | Dentzer James E | President & CEO | C | Series B Convertible Preferred Stock | 100 | $0.00 | 0.0000 | 15,680,178 | 100.00% | 0.00% |
| March 20, 2026 | CURIS INC | $CRIS | Dentzer James E | President & CEO | C | Common Stock | 133333 | $0.00 | 148,730.0000 | 15,680,178 | 865.97% | 0.85% |
| March 17, 2026 | CURIS INC | $CRIS | Dentzer James E | President & CEO | A | Series C Warrant (right to buy) | 133333 | $0.00 | 133,333.0000 | 15,680,178 | 9999.99% | 0.85% |
| March 17, 2026 | CURIS INC | $CRIS | Dentzer James E | President & CEO | A | Series B Convertible Preferred Stock | 100 | $0.00 | 100.0000 | 15,680,178 | 9999.99% | 0.00% |
| March 17, 2026 | CURIS INC | $CRIS | Dentzer James E | President & CEO | A | Series A Warrant (right to buy) | 133333 | $0.00 | 133,333.0000 | 15,680,178 | 9999.99% | 0.85% |
| March 17, 2026 | CURIS INC | $CRIS | Dentzer James E | President & CEO | A | Series B Warrant (right to buy) | 133333 | $0.00 | 133,333.0000 | 15,680,178 | 9999.99% | 0.85% |
| Jan. 2, 2026 | Imunon, Inc. | $IMNN | Dentzer James E | Director | A | Stock Option (Right to Buy) | 4405 | $0.00 | 4,405.0000 | 3,070,354 | 9999.99% | 0.14% |
| Aug. 4, 2025 | Imunon, Inc. | $IMNN | Dentzer James E | Director | A | Common Stock | 3318 | $9.20 | 3,318.0000 | 14,620,732 | 9999.99% | 0.02% |
| Aug. 4, 2025 | Imunon, Inc. | $IMNN | Dentzer James E | Director | A | Stock Option (Right to Buy) | 250 | $0.00 | 250.0000 | 14,620,732 | 9999.99% | 0.00% |
| May 20, 2025 | CURIS INC | $CRIS | Dentzer James E | President & CEO | A | Employee stock option (right to buy) | 360000 | $3.13 | 360,000.0000 | 6,306,284 | 9999.99% | 5.71% |
| March 14, 2025 | Imunon, Inc. | $IMNN | Dentzer James E | Director | A | Stock Option (Right to Buy) | 3750 | $0.00 | 3,750.0000 | 14,620,732 | 9999.99% | 0.03% |
| Jan. 28, 2025 | CURIS INC | $CRIS | Dentzer James E | President & CEO | A | Employee stock option (right to buy) | 40000 | $3.13 | 40,000.0000 | 6,306,284 | 9999.99% | 0.63% |
| Sept. 6, 2024 | Imunon, Inc. | $IMNN | Dentzer James E | Director | A | Stock Option (Right to Buy) | 3634 | $0.00 | 17,301.0000 | 0 | 26.59% | 0.00% |
| June 12, 2024 | Imunon, Inc. | $IMNN | Dentzer James E | Director | A | Stock Option (Right to Buy) | 4500 | $0.00 | 13,667.0000 | 0 | 49.09% | 0.00% |
| May 21, 2024 | CURIS INC | $CRIS | Dentzer James E | President & CEO | A | Employee stock option (right to buy) | 100000 | $11.62 | 100,000.0000 | 5,293,294 | 9999.99% | 1.89% |
| March 15, 2024 | Imunon, Inc. | $IMNN | Dentzer James E | Director | A | Stock Option (Right to Buy) | 4500 | $0.00 | 9,167.0000 | 0 | 96.42% | 0.00% |
| March 17, 2023 | Imunon, Inc. | $IMNN | Dentzer James E | Director | A | Stock Option (Right to Buy) | 2000 | $0.00 | 4,667.0000 | 0 | 74.99% | 0.00% |
| Jan. 20, 2023 | CURIS INC | $CRIS | Dentzer James E | President & CEO | A | Employee stock option (right to buy) | 1000000 | $0.00 | 1,000,000.0000 | 0 | 9999.99% | 0.00% |